Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 3/20 | 0.59 |
| ▸ | CA1 | P00915 | 3/20 | 0.59 |
| ▸ | CA2 | P00918 | 3/20 | 0.59 |
| ▸ | CA7 | P43166 | 3/20 | 0.59 |
| ▸ | CA9 | Q16790 | 3/20 | 0.59 |
| ▸ | CA14 | Q9ULX7 | 3/20 | 0.59 |
| ▸ | ESR1 | P03372 | 1/20 | 0.44 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.44 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.43 |
| ▸ | NR1H3 | Q13133 | 1/20 | 0.43 |
| ▸ | HTT | P42858 | 1/20 | 0.42 |
| ▸ | F2 | P00734 | 2/20 | 0.40 |
| ▸ | F10 | P00742 | 2/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | SLC22A2 | O15244 | 1/20 | 0.40 |
| ▸ | TMPRSS2 | O15393 | 1/20 | 0.40 |
| ▸ | PLG | P00747 | 1/20 | 0.40 |
| ▸ | F12 | P00748 | 1/20 | 0.40 |
| ▸ | PLAU | P00749 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2875378 | 0.92 | CA12 (0.56) | CA12CA1CA2CA7CA9 | |
| SCHEMBL14374036 | 0.77 | CA12 (0.73) | CA12CA1CA2CA7CA9 | |
| SCHEMBL5415007 | 0.77 | CA12 (0.73) | CA12CA1CA2CA7CA9 | |
| SCHEMBL475700 | 0.77 | CA12 (0.92) | CA12CA1CA2CA7CA9 | |
| SCHEMBL39026 | 0.77 | CA12 (1.00) | CA12CA1CA2CA7CA9 | |
| SCHEMBL16326875 | 0.76 | PLA2G2A (0.47) | CA12CA1CA2CA7CA9 | |
| SCHEMBL57016 | 0.74 | CA12 (0.79) | CA12CA1CA2CA7CA9 | |
| SCHEMBL8655756 | 0.73 | KMT2A (0.48) | CA12CA1CA2CA7CA9 | |
| SCHEMBL19809534 | 0.72 | CA12 (0.59) | CA12CA1CA2CA7CA9 | |
| SCHEMBL2257945 | 0.72 | CA12 (0.81) | CA12CA1CA2CA7CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10383841-B2 | Antimicrobial and antiinflammatory composition | DENOVASTELLA AB (SE) | 2019-08-20 | — | — | US | disclosed |
| EP-2150119-B1 | DIHYDROXYBENZOATE POLYMERS AND USES THEREOF | TYRX INC (US) | 2018-04-11 | — | — | EP | disclosed |
| US-9491966-B2 | Dihydroxybenzoate polymers and uses thereof | TYRX, INC. (US) | 2016-11-15 | — | — | US | disclosed |
| EP-1898893-B1 | ANTIMICROBIAL COMPOSITION | DENOVASTELLA AB (SE) | 2014-09-24 | — | — | EP | disclosed |
| US-20130245112-A1 | ANTIMICROBIAL AND ANTIINFLAMMATORY COMPOSITION | DENOVASTELLA AB (SE) | 2013-09-19 | — | — | US | disclosed |
| US-20100331401-A1 | ANTIMICROBIAL AND ANTIINFLAMMATORY COMPOSITION | DENOVASTELLA AB (SE) | 2010-12-30 | — | — | US | disclosed |
| US-20100129417-A1 | Dihydroxybenzoate Polymers and Uses Thereof | MEDTRONIC, INC. | 2010-05-27 | — | — | US | disclosed |
| EP-2150119-A1 | DIHYDROXYBENZOATE POLYMERS AND USES THEREOF | TYRX PHARMA INC. (US) | 2010-02-10 | — | — | EP | disclosed |
| WO-2008137807-A1 | DIHYDROXYBENZOATE POLYMERS AND USES THEREOF | TYRX PHARMA, INC. (US) | 2008-11-13 | — | — | WO | disclosed |
| US-20080249164-A1 | Antimicrobial and Antinflammatory Composition | DENOVASTELLA AB (SE) | 2008-10-09 | — | — | US | disclosed |
| EP-1898893-A1 | ANTIMICROBIAL AND ANTIINFLAMMATORY COMPOSITION | Denovastella AB (SE) | 2008-03-19 | — | — | EP | disclosed |
| WO-2007004952-A1 | ANTIMICROBIAL AND ANTIINFLAMMATORY COMPOSITION | DENOVASTELLA AB (SE) | 2007-01-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100129417-A1 | Dihydroxybenzoate Polymers and Uses Thereof | DDT, QDPR, HPD | CA12 2991/4885CA1 3801/4885CA2 3493/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.